From the Journals

ACOG stresses widespread prepregnancy carrier screening


 

FROM OBSTETRICS & GYNECOLOGY

The American College of Obstetricians and Gynecologists is calling on ob.gyns. to establish a standard carrier screening process that is consistently offered to all patients before pregnancy.

This a shift from previous ACOG policy, which recommended carrier screening based mainly on ethnicity.

In a pair of opinions from ACOG’s Committee on Genetics, they highlighted three acceptable screening methods: ethnic-specific screening, panethnic screening, and expanded-carrier screening (Obstet Gynecol. 2017;129:e35-40/Obstet Gynecol. 2017;129:e41-55).

Panethnic and expanded-carrier screening are especially helpful for patients with parents of different ethnic backgrounds or those who do not know their family history, situations that have become more common.

Dr. Joseph R. Biggio, of Birmingham, Alabama

Dr. Joseph R. Biggio

As these testing options are equally viable, preassigned testing options will save physicians, patients, and the health care system from being overwhelmed, according to Joseph R. Biggio Jr., MD, chair of the ACOG Committee on Genetics.

“In reality, over the last 5-7 years, the amount an obstetrician has to counsel patients on carrier screening and prenatal screening has grown immensely,” Dr. Biggio said in an interview. “Trying to find the time to do it and do it well, is a challenge. What is important is all practitioners have a way to approach offering carrier screening in their practice setting.”

While the committee advises crafting a process that fits individual practice needs, there are some general recommendations:

  • Test only for diseases with a carrier frequency of 1 in 100 or greater, have a well-defined phenotype, have a detrimental effect on quality of life, cause cognitive or physical impairment, require surgical or medical intervention, or have an onset early in life.
  • All patients, regardless of screening strategy and ethnicity, should be checked for cystic fibrosis and spinal muscular atrophy, and also undergo a complete blood count and screening for thalassemias and hemoglobinopathies.
  • Prenatal carrier screening does not replace newborn screening, and at the same time, newborn screening does not diminish the potential benefits of prenatal carrier screening.

“Practitioners should be testing patients for these diseases as early as possible,” Dr. Biggio said. “A consistent approach to screening consultation will help with that immensely.”

On Twitter @EAZTweets

Recommended Reading

Perinatal depression screening is just the start
MDedge ObGyn
PrEP appears to be safe in pregnancy
MDedge ObGyn
Term ultrasound shown unreliable for diagnosing macrosomia
MDedge ObGyn
Prenatal surveillance vital in monochorionic twin pregnancies
MDedge ObGyn
Early delivery by morbidly obese moms improves outcomes
MDedge ObGyn
Monofilament suture works best for cesarean closure
MDedge ObGyn
Antihypertensive protocol cuts eclampsia rates
MDedge ObGyn
Product Update: Sureglide Cesarean Scalpel; Viveve Medical; NovaSure ADVANCED
MDedge ObGyn
She wanted to labor on hands and knees
MDedge ObGyn
How and when umbilical cord gas analysis can justify your obstetric management
MDedge ObGyn